Ipozumax (Itraconazole)

Itraconazole blocks the fungal enzyme lanosterol 14α-demethylase, a key step in producing ergosterol, an essential component of fungal cell membranes. Without ergosterol, the membrane becomes defective, leading to increased permeability and cell death. This selective inhibition targets fungi while sparing human cells.

The exact dosage of Ipozumax is determined by the prescribing clinician based on the specific infection, its severity, patient weight, renal and hepatic function, and other individual factors. Healthcare professionals tailor the regimen to achieve optimal therapeutic outcomes while minimizing risk.

Safety data for itraconazole in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives and risks with their healthcare provider.

To request Ipozumax, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain needs) and required import documentation.

Itraconazole offers a broad spectrum against many systemic and superficial fungi and has a longer half‑life than fluconazole, allowing once‑daily dosing for some indications. Compared with newer agents like voriconazole, itraconazole may have fewer drug‑interaction concerns but can be less potent against certain molds. Choice depends on infection type, patient factors and susceptibility data.

Ipozumax should be stored at ambient temperature below 25 °C, in its original packaging to protect from moisture and light. Keep the product out of reach of children and avoid storing in bathrooms or other humid environments.

Ipozumax is taken orally, usually with a full glass of water. The tablet or capsule should be swallowed whole and not chewed or crushed unless directed by a pharmacist. Food may affect absorption, so patients should follow the prescribing clinician’s instructions regarding meals.

Serious risks include hepatotoxicity, which may present as jaundice or elevated liver enzymes, and congestive heart failure due to fluid retention. Patients should be monitored for signs of liver dysfunction or worsening cardiac symptoms, and therapy should be discontinued if severe adverse events occur.

Ipozumax is contraindicated in patients with known hypersensitivity to itraconazole or any azole antifungal. It should also be avoided in individuals with uncontrolled heart failure, severe hepatic impairment, or those taking medications that have a known major interaction that cannot be managed.